Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Zymeworks Inc
ZYME
Healthcare
Biotechnology
Zymeworks Inc. is a global biotechnology company. The Company is engaged in the discovery, development, and commercialization of multifunctional biotherapeutics to treat cancer and other serious diseases. Its complementary therapeutic platforms and fully integrated drug development engine provide the flexibility and compatibility to precisely engineer and develop differentiated antibody-based...
therapeutic candidates. Its platforms include Azymetric, Drug Conjugate Platforms, EFECT, and ProTECT. Its lead product candidate, zanidatamab, is a bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2). Its second product candidate, zanidatamab zovodotin, combines the biparatopic antibody design of zanidatamab with its ZymeLink auristatin antibody-drug conjugate (ADC) technology, comprised of its cytotoxin (cancer cell-killing compound) and cleavable linker. Its pipeline includes four preclinical candidates: ZW191, ZW171, ZW220, and ZW251.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ZYME)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(1918)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Post by
Possibleidiot01
on Nov 21, 2024 7:11pm
Globe and Mail headline
Rare milestone for Canadian biotech as Zymeworks-developed drug gets FDA approval
(9)
•••
MikeTester
X
View Profile
View Bullboard History
Post by
MikeTester
on Aug 02, 2024 7:27am
Zymeworks Inc. (NASDAQ:ZYME): Advancing a Diverse Pipeline o
https://beyondspx.com/2024/08/01/zymeworks-inc-nasdaqzyme-advancing-a-diverse-pipeline-of-novel-biotherapeutics/
QMET has 11 claims and 633 hectares Property in Ville-Marie, Quebec Hydrogen Camp
posted Nov 25, 2024 9:00am by
Q Precious & Battery Metals Corp.
-
|
The Company is pleased to discover that their Lorrain claims are now within the new and exciting exploration for hydrogen in the Ville-Marie, Lorrainville and Béarn region of Quebec. The region has undergone a claim staking rush following the ...read more
(1918)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Post by
Possibleidiot01
on May 16, 2023 6:50am
Paradigm - cantechletter.com
Zymeworks gets a target trim from Paradigm Paradigm Capital analyst Scott McAuley lowered his target a notch on biopharma developer Zymeworks (Zymeworks Stock Quote, Charts, News, Analysts
...more
(122)
•••
Gringotts
X
View Profile
View Bullboard History
Post by
Gringotts
on Mar 08, 2023 8:51am
As some have noted..
Yesterday's quarterly and yearly results, smashed earnings and revenue estimates. ZYME is ridiculously undervalued. Lets see if the market finally wakes up to the very positive ZYME
...more
(85)
•••
7Twiggy
X
View Profile
View Bullboard History
Comment by
7Twiggy
on Nov 15, 2022 11:35am
RE:ZYME contiuing it's trend up
And one she goes this morning. Over 8.70 and shows no signs of slowing down.
(85)
•••
7Twiggy
X
View Profile
View Bullboard History
Post by
7Twiggy
on Nov 10, 2022 2:37pm
ZYME contiuing it's trend up
Continues it's trend up. Moved through 8.00 and showing a lot of strength these past two weeks. Some good posts of Yahoo finance and Stocktwits. So far this board dead. Short
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 04, 2022 6:05pm
New Press Release - Zymeworks Announces Release of ESMO Abstract for Phase 1 Study of Zanidatamab Zovodotin (ZW49) in Solid Cancers
Zanidatamab zovodotin shown to have manageable safety profile with encouraging, single-agent anti-tumor activity in patients with HER2+ cancersResults to be reviewed in an oral presentation at European Society for Medical Oncology (ESMO) Congress 2022 in Paris Monday, September 12 at 5:25 pm...
read article.
(85)
•••
7Twiggy
X
View Profile
View Bullboard History
Post by
7Twiggy
on Aug 12, 2022 4:06pm
I think we are headed into double digits sooner than later.
Another great day for Zymeworks. Another 6 percent up. Higher highs and lower lows the name of the game. I think we are headed into double digits sooner than later. This board still
...more
(85)
•••
7Twiggy
X
View Profile
View Bullboard History
Post by
7Twiggy
on Aug 11, 2022 7:46pm
Looks to me like Zyme is on its way back.
Looks to me like Zyme is on its way back. Continue to add on positive moves up. Should see continued move up as we head to those September conferences. Another great day. Added again yesterday and am
...more
(122)
•••
Gringotts
X
View Profile
View Bullboard History
Comment by
Gringotts
on Aug 06, 2022 9:37pm
RE:News Release?
Sorry...I'm wrong. Galbraith is still in his position as CEO. Darn! Form 8-K (sec.gov)
(122)
•••
Gringotts
X
View Profile
View Bullboard History
Post by
Gringotts
on Aug 06, 2022 8:48pm
News Release?
The market needs an official press release to prove this useless CEO has been turfed. I hope ZYME can soon recover from this nightmare CEO.
(122)
•••
Gringotts
X
View Profile
View Bullboard History
Comment by
Gringotts
on Aug 06, 2022 7:45pm
RE:Could this be the start of a move up?
I, as sure as h.ell, hope so! Galbraith is a nightmare. I hope this is true.
(85)
•••
7Twiggy
X
View Profile
View Bullboard History
Post by
7Twiggy
on Aug 05, 2022 7:19pm
And more
By Albert Van Santvoort | May 6, 2019, 11:55pm Neil Klompas, CFO, Zymeworks | Chung Chow When
...more
(85)
•••
7Twiggy
X
View Profile
View Bullboard History
Post by
7Twiggy
on Aug 05, 2022 7:15pm
Bio new pres
Neil Klompas EVP, Business Operations & CFO Join to edit Mr. Klompas joined Zymeworks in March 2007 and currently serves as the Executive Vice President, Business Operations and
...more
(85)
•••
7Twiggy
X
View Profile
View Bullboard History
Post by
7Twiggy
on Aug 05, 2022 7:03pm
Could this be the start of a move up?
8-K Emp Changes Reg FD – Zymeworks Inc. (0001403752) August 04 Posted on August 5, 2022 ByNews Desk ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS
...more
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario